Chargement en cours...
Patient Diaries As a Clinical Endpoint in Parkinson's Disease Clinical Trials
Parkinson's disease (PD) is the second most common neurodegenerative disorder with an estimated 4 million patients worldwide. L‐dopa is standard, and often initial, therapy for patients with this condition; however, with continued dopaminergic treatment and as the disease progresses, the majori...
Enregistré dans:
| Publié dans: | CNS Neurosci Ther |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Blackwell Publishing Ltd
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6493659/ https://ncbi.nlm.nih.gov/pubmed/22070400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2011.00253.x |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|